News & Insights

CEO Thomas H. Grimstad, M.D. Announces Retirement

May 09, 2018

CEO Thomas H. Grimstad, M.D. Announces Retirement

After more than 20 years with LAMMICO, Thomas H. Grimstad, M.D., (pictured right) has announced his retirement as LAMMICO President and CEO effective March 1, 2019. The Board of Directors has elected LAMMICO’s current Board Chairman, J. Michael Conerly, M.D., to succeed Dr. Grimstad as President and CEO.

Dr. Grimstad received his bachelor's degree from the University of Wisconsin and his M.D. degree from the Tulane University School of Medicine. He is Board Certified in Internal Medicine and Pulmonary Disease and began practicing in the New Orleans metropolitan area in 1977.

Dr. Grimstad joined LAMMICO as a member of the Risk Management Committee in 1995 and was elected to the Board of Directors in 1998. He has also served on the Claims Committee and was appointed Senior Vice President of the Underwriting Committee in 1999. He served in that capacity until October 2005, when he became the Senior Vice President of LAMMICO’s Underwriting Department. In January 2008, Dr. Grimstad was named LAMMICO’s President and CEO.

Dr. Conerly is a long-standing member of LAMMICO leadership having served as a member of the Executive, Marketing, Underwriting & Joint Risk Assessment, Governance and Audit Committees over the last 20 years. He was elected to his current role as Chairman of the Board of Directors in 2011.

Drs. Grimstad and Conerly will work closely together in the coming months through an established transition plan. Upon his retirement, Dr. Grimstad will remain a member of the LAMMICO Board of Directors.

We thank Dr. Grimstad, Dr. Conerly and the Board of Directors for their many years of dedicated service, including a commitment to succession planning to ensure a smooth transition. We are grateful for Dr. Grimstad's continued leadership and look forward to welcoming Dr. Conerly as he becomes the fifth physician to lead our Company in its more than 35 year history.

Recommended Reading For You

COVID-19 Added to Class A Reportable Diseases List

Read More

LAMMICO Declares a 5% Policyholder Dividend

Read More

LAMMICO’s “A” Rating Reaffirmed by AM Best

Read More


Annual Reports:

Receive Regular Updates: